Pharmaceutical Companies directories

    Pharmaceutical Companies by country

    This hub gathers every BioNixus pharmaceutical company directory in one place, from the original Gulf and Egypt lists that market-access teams have used since 2025 to the Africa, South-East Asia, Latin America and European pages added in 2026. Each country page names the domestic manufacturers, the multinational affiliates with a registered presence, the regional groups that treat the market as part of a wider footprint, and the regulator or public buyer that governs registration and tenders.

    The pages share one structure so a portfolio team can compare markets quickly: a classified company table, the registration and channel path a product follows, three or four sourced market statistics, the growth drivers analysts watch, and the register the list was checked against with an as-of date. Where BioNixus also publishes a distributor, pharmacy-chain or hospital-group directory for the same country, the pharmaceutical page links to it so the whole supply chain can be mapped from one entry point.

    Directories are grouped below by region. Countries with a medicines regulator that publishes a public licence register (SFDA, MOHAP, EDA, TİTCK, DRAP, SAHPRA, BPOM, COFEPRIS, ANVISA, AIFA, AEMPS, ANSM, HPRA and others) are refreshed against that register; the remainder rely on stock-exchange filings, manufacturer associations and BioNixus fieldwork.

    Browse the directoriesSee how teams use them

    54

    directories in this hub

    54

    countries covered

    1

    company types

    48h

    to a scoped proposal

    Pharmaceutical Companies

    Pharmaceutical Companies by country

    Every pharmaceutical company directory BioNixus maintains, grouped by region. Each page carries 12–25 named accounts, the distributors & importers layer, growth drivers and a country proposal form.

    GCC

    BahrainPharmaceutical Companies in BahrainKuwaitPharmaceutical Companies in KuwaitOmanPharmaceutical Companies in OmanQatarPharmaceutical Companies in QatarSaudi ArabiaPharmaceutical Companies in Saudi ArabiaUnited Arab EmiratesPharmaceutical Companies in the UAE

    Wider MENA & Turkey

    AlgeriaPharmaceutical Companies in AlgeriaEgyptPharmaceutical Companies in EgyptIranPharmaceutical Companies in IranIraqPharmaceutical Companies in IraqJordanPharmaceutical Companies in JordanLebanonPharmaceutical Companies in LebanonLibyaPharmaceutical Companies in LibyaMoroccoPharmaceutical Companies in MoroccoTunisiaPharmaceutical Companies in TunisiaTurkeyPharmaceutical Companies in TurkeyYemenPharmaceutical Companies in Yemen

    Africa

    EthiopiaPharmaceutical Companies in EthiopiaKenyaPharmaceutical Companies in KenyaNigeriaPharmaceutical Companies in NigeriaSouth AfricaPharmaceutical Companies in South Africa

    Europe

    BelgiumPharmaceutical Companies in BelgiumFrancePharmaceutical Companies in FranceGermanyPharmaceutical Companies in GermanyIrelandPharmaceutical Companies in IrelandItalyPharmaceutical Companies in ItalyNetherlandsPharmaceutical Companies in the NetherlandsPolandPharmaceutical Companies in PolandSpainPharmaceutical Companies in SpainSwedenPharmaceutical Companies in SwedenSwitzerlandPharmaceutical Companies in SwitzerlandUnited KingdomPharmaceutical Companies in the UK

    North America

    CanadaPharmaceutical Companies in CanadaUnited StatesPharmaceutical Companies in the USA

    Latin America

    ArgentinaPharmaceutical Companies in ArgentinaBrazilPharmaceutical Companies in BrazilChilePharmaceutical Companies in ChileColombiaPharmaceutical Companies in ColombiaMexicoPharmaceutical Companies in MexicoPeruPharmaceutical Companies in Peru

    Asia-Pacific

    AustraliaPharmaceutical Companies in AustraliaBangladeshPharmaceutical Companies in BangladeshChinaPharmaceutical Companies in ChinaIndiaPharmaceutical Companies in IndiaIndonesiaPharmaceutical Companies in IndonesiaJapanPharmaceutical Companies in JapanKazakhstanPharmaceutical Companies in KazakhstanMalaysiaPharmaceutical Companies in MalaysiaPakistanPharmaceutical Companies in PakistanPhilippinesPharmaceutical Companies in the PhilippinesSingaporePharmaceutical Companies in SingaporeSouth KoreaPharmaceutical Companies in South KoreaThailandPharmaceutical Companies in ThailandVietnamPharmaceutical Companies in Vietnam

    Who this is for

    What these directories are for

    Multi-country launch sequencing

    Compare the manufacturer base, MNC presence and public-buyer concentration across candidate markets before deciding where a molecule launches first.

    Licensing and partner screening

    Identify the local manufacturers with the portfolio, plant and tender record to license, co-market or contract-manufacture a brand in each country.

    Competitive share-of-voice studies

    Turn a country list into a prescriber or pharmacist tracker that measures awareness, detailing recall and preference for every named company.

    Questions

    Frequently Asked Questions

    How is a company chosen for a pharmaceutical directory?

    A company appears when it holds marketing authorisations or a manufacturing licence in the country, is visible in public tenders or exchange filings, and recurs in BioNixus prescriber, pharmacist or purchaser fieldwork. Pure importers without a registered affiliate are listed on the distributor pages instead.

    Are multinationals listed under every country where they sell?

    Only where they operate a registered affiliate, a plant or a scientific office. A multinational that sells purely through an agent is covered on the country’s distributor directory, which keeps the two intents distinct.

    Why do some countries show fewer companies than others?

    The table length follows the size of the licensed manufacturer base and the depth of BioNixus fieldwork. Smaller or more fragmented markets carry 12–16 names; large manufacturing countries carry 20 or more.

    Can BioNixus profile a specific pharmaceutical company in one of these countries?

    Yes. Account-level studies — prescriber perception, pharmacist share-of-recommendation, tender and formulary tracking, and field-force effectiveness — are scoped through the proposal form on each country page.

    48-hour proposal

    Need account-level data on any of these companies?

    Tell us the market, the accounts and the decision. BioNixus scopes a primary-research proposal within 48 hours.

    Planning research in Global?

    Primary research, market access & HEOR. Proposals within 48 hours.